Back to Library
Peptide Library / Detail
Reta - GLP-3
Investigational Multi-Agonist PeptideResearch use only
Half-life
Approximately 5–7 days
Delivery
Subcutaneous injection (weekly)
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Purchase
Description
Reta GLP-3 is a triple agonist targeting GLP-1, GIP, and glucagon receptors, being explored for its powerful metabolic effects, especially in obesity and type 2 diabetes.
Usage
Used in clinical trials and investigational studies for significant body fat reduction, appetite control, and glucose management.
Mechanism of Action
Acts on GLP-1, GIP, and glucagon receptors to enhance insulin sensitivity, reduce appetite, and increase energy expenditure.
Benefits(3)
- Substantial weight loss
- Improved glycemic control
- Enhanced metabolic rate
Side Effects(3)
- Nausea
- Gastrointestinal discomfort
- Possible increased heart rate